Shenzhen Neptunus Bioengineering Co., Ltd.

Share · CNE000000X95 (XSHE)

Overview

No Price

Closing Price XSHE 30.01.2026: 3,69 CNY

30.01.2026 07:04

Current Prices from Shenzhen Neptunus Bioengineering Co., Ltd.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
SHENZHEN STOCK EXCHANGE	000078.SZ	CNY	30.01.2026 07:04	3,69 CNY	-0,11 CNY -2,89 %

Share Float & Liquidity

Free Float 52,86 %

Shares Float 1,39 B

Shares Outstanding 2,63 B

Company Profile for Shenzhen Neptunus Bioengineering Co., Ltd. Share

Shenzhen Neptunus Bioengineering Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products primarily in China. It offers drugs in the fields of anti-tumor, cardio-cerebrovascular, marine drugs, and other fields. The company was founded in 1989 and is based in Shenzhen, China.

AI Analysis of Shenzhen Neptunus Bioengineering Co., Ltd.

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Shenzhen Neptunus Bioengineering Co., Ltd.

No AI threads available for this company yet.

Company Data

Name Shenzhen Neptunus Bioengineering Co., Ltd.

Company Shenzhen Neptunus Bioengineering Co., Ltd.

Website https://www.neptunus.com

Primary Exchange

SHENZHEN STOCK EXCHANGE

ISIN CNE000000X95

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Feng Zhang

Market Capitalization 10 Mrd.

Country China

Currency CNY

Employees 9,1 T

Address Wang Yinhe Technology Building, 518057 Shenzhen

IPO Date 1998-12-18

Ticker Symbols

Name	Symbol
SHENZHEN STOCK EXCHANGE	000078.SZ

More Shares

Investors who hold Shenzhen Neptunus Bioengineering Co., Ltd. also have the following shares in their portfolio:

HEATHROW FUNDING LIMITED SUB CLS A-19 IDX BNDS 25/04/2024 Bond

KRED.F.WIED.25/37 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog